Delivery Order SPE2DB20D3103-SPE2DB25FN6W0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $118,769.69 to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The contract, awarded on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.66 to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The award was made on May 16, 2025, with an ultimate completion date of May 19, 2025, utilizing firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,451.50 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The contract is a firm fixed price delivery order with an ultimate completion date of December 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,517.62 to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. The order is scheduled for completion by September 3, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $146,369.15 delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML meningococcal vaccine, with an ultimate completion date of November 26, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded competitively on November 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $92,818.40 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This competitively awarded, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency awarded a $2,195.49 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The order is scheduled for completion by June 2, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $109,773.00 for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine product. The contract was competitively awarded without a set-aside designation and is structured as a firm fixed price delivery order with an ultimate completion date of April 25, 2025. Performance will take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,664.99 for Menveo 1 vial (A-C-Y-W-135-DIP 0.5ML), a meningococcal conjugate vaccine. The contract was competitively awarded without set-aside designation and is scheduled for completion by August 14, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN6W0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $94,993.90 to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a conjugate meningococcal vaccine. The contract was competitively awarded without set-aside restrictions and carries a firm fixed price structure, with performance to be completed by May 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its corporate office location in the same jurisdiction. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs, with products distributed to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The vaccine delivery represents one of numerous medical commodity fulfillments AmerisourceBergen Drug Corp provides through this framework, supporting federal medical procurement needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $95.0k | 5/2/25 |